JAN 18, 2016 08:42 AM PST

Eye Movement and Alzheimer's Disease

Alzheimer’s disease (AD) and other forms of dementia are on the rise. There is no known cause of AD and there isn’t even a definitive way to diagnose the disease until after a person has died. A key area in neuroscience research is the search for an early test for AD so that patients and their families can have time to arrange care and look for ways to deal with the memory loss and other factors.
New research could identify Alzheimer's disease earlier

The most recent figures show that approximately 5.1 million Americans might be suffering from the effects of Alzheimer’s disease. And those figures are going up. Current research from the National Institute on Aging indicates that the prevalence of Alzheimer's disease doubles every five years beyond age 65.  By the year 2050 the costs of treating AD could rise to $1.1 trillion, up from the $226 billion estimated through the year 2015. Finding a way to test for the disease has become a crucial part of the research surrounding Alzheimer’s disease. 
 
Chilean neurologists however may have found a process for diagnosing Alzheimer's disease early, even before memory loss and other symptoms develop. Researchers at Chile's Biomedical Neuroscience Institute (BNI) believe they can identify early stages of dementia and even some other psychiatric and neurological diseases by observing eye movement patterns and the brain's electrical activity. Using a computer simulation game with virtual reality technology the neurologists in Chile studied patients playing along in a game where they  had to navigate through a virtual landscape and find "keys" to complete a task. Lead neurologist Enzo Brunetti said the tests were able to detect very early signs of cognitive impairment, even in patients who showed no symptoms. 
 
Brunetti told Reuters, "In this study, what we did was that we applied spatial navigation tasks using a computer, and with the help of a software we examined in detail which were the early functions that became altered in Alzheimer's disease (patients) and focused on a very specific function, linked to the codification and development of cognitive memory, that helps people move through the physical environment. This is one of the cognitive functions that were altered in patients with Alzheimer's and we observed that they were altered from very early stages. Therefore we believe this is a biomarker for the disease, which would give us an opportunity to shed light on an early diagnosis for this disease." 

The team in Chile also fitted study participants with caps containing electrodes and conducted EEG testing while the patients were navigating through the game. This monitoring, along with recording the eye movements of patients convinced Brunetti that diagnosing AD before significant memory loss and cognitive impairment is vital to helping patients and that a larger clinical trial is necessary to fine tune the process. Take a look at the video below to learn more about the study and how it could impact dementia patients and their families.
 
 
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JAN 20, 2020
Neuroscience
JAN 20, 2020
How 'Magic Mushrooms' Can Help Smokers Quit
The Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine does not look like your average doctor's office - there are couches, paintings of natural scenery, and glowing...
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Linking Genes and Behavior in an Assessment of Personality in Animals
Anyone that's owned dogs knows that they have a personality, and the same is true of mice....
JAN 20, 2020
Neuroscience
JAN 20, 2020
Are teens addicted to their phones?
Journalists quickly jumped to the conclusion that 23% of teenagers are addicted to their smartphones thanks to findings from a new study from King’s ...
JAN 20, 2020
Neuroscience
JAN 20, 2020
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
JAN 20, 2020
Neuroscience
JAN 20, 2020
Hand-Motion Center of the Brain Involved in Speech
During a long-term study focused on improving computer-assistant interfaces for quadriplegia patients, researchers at Stanford University were able to use...
JAN 20, 2020
Neuroscience
JAN 20, 2020
Fewer Connections Between Brain Cells for Schizophrenia
Approximately 1% of the world’s population have schizophrenia, with 3.2 million Americans having the disorder. Now, for the first time, advanced brai...
Loading Comments...